|
|
 |
 |
 |
| List of Posters |
| |
|
Diabetes
|
|
|
Board # |
Poster Title & Author(s)
|
|
|
D1 |
Association of FABP2 Ala54Thr polymorphism with type 2 diabetes in Chilean elders
C. Albala, A. Villarroel, B. Angel, J. Santos, L. Lera, H. Sanchez, C. Liberman, F.Perez-Bravo, Chile
|
|
|
D2 |
Is There Any Association Between Income Levels and Health Related Quality of Life at Diabetic Patients?
N.N. Altiner, F. Topcugil, I. Oktem Kavalalý, S. Demirboga, S. L. Aslan, Turkey
|
|
|
D3 |
Measures That Can Be Used To Determine Quality of Life Associated with Diabetes
N.N. Altiner, F. Topçugil, G. Oruk, S. L. Aslan, Turkey
|
|
|
D4 |
The Prevalence of Diabetic Retinopathy in Diabetic Patients with History of Diabetic Foot Ulcer
M.N. Atakoglu, F. Gokdogan, F. Yýlmaz, N. Xafak Yis, H. Koca, S. Yorgun, S. Can, H.Alpteker, Turkey
|
|
|
D5 |
MORNING CONSUMPTION OF RESISTANT STARCH REDUCES BLOOD GLUCOSE AND INSULIN RESPONSE TO A STANDARDIZED LUNCH MEAL
K.M. Behall, D. J. Scholfield, J.G. Hallfrisch, USA
|
|
|
D6 |
Celiac disease and diabetes mellitus connection
A.C. Bentley, USA
|
|
|
D7 |
Diabetogenic effects of urbanization
M. Boz, E. Ulgen, C. Muderrisoglu, F. Erdenen, E. Altunoglu, F. Sametoglu, Turkey
|
|
|
D8 |
The evaluation and improvement of metabolic control in type 1 and type 2 diabetes mellitus with continuous glucose monitoring system
A.C. Carvalho, I. Palma, C. Amaral, S. Pinto, F. Borges, Portugal
|
|
|
D9 |
Diabetes compensation from the standpoint of a physisist
I.A. Chaikovsky, Israel
|
|
|
D10 |
Doctor/diabetic team-work in on-line mode as the only efficient method of diabetes compensation
I.A. Chaikovsky, Israel
|
|
|
D11 |
Incidence and characteristics of diabetic peripheral neuropathy in relation to metabolic syndrome (using both NCEP and IDF criteria) in type II diabetic patients
S.D. Chondropoulos, E. Zervas, K.B. Korovesis, I. A. Kyriazis, A. Lalousis, A. Markellos, C. Partheniou, Greece
|
|
|
D12 |
Incidence and characteristics of diabetic nephropathy in relation to metabolic syndrome (IDF2005 criteria) in type II diabetic patients
S.D. Chondropoulos, E. Zervas, I.A. Kyriazis, K. Paraskevopoulos, A. Manias, A. Vourtsi, C. Partheniou, Greece
|
|
|
D13 |
Estimation of the risk for type 2 diabetes mellitus in patients diagnosed as metabolic syndrome using ATP III and IDF 2005 criteria
P.B. Djordjevic, V. Dimitrijevic Sreckovic, F. M. Canovic, D. Gostiljac, T. Novakovic, T. Nisic, G. Milic, M.Ilic, S. Popovic, D. Nikolic,M. Gaijc, Serbia
|
|
|
D14 |
Vascular topography of glycemia in “normoglycemic” type 1 diabetecs (theoretical analysis)
A.V. Dreval, Russia
|
|
|
D15 |
Correlation between HbA1c level and OGTT parameters in type 2 diabetic patients
A.V. Dreval, J. A. Redkin,V. Bogomolov, Russia
|
|
|
D16 |
FLUCTUATIONS IN GLYCOSYLATED HEMOGLOBIN (HBA1C) AS A PREDICTOR FOR THE DEVELOPMENT OF DIABETIC NEPHROPATHY IN TYPE 1 DIABETIC PATIENTS
J.E. Fares, M. Kenaan, C. Monique, S.T. Azar, Lebanon
|
|
|
D17 |
New method of heart electrophysiology examination in type 2 dibetes (DM2) patients
S.I. Fedorova, V.P. Pronina, T.Y. Lebedeva, M.P. Reva, A.S. Sula, Russia
|
|
D18 |
Iron markers are not found to be elevated in gestational diabetic mothers in a Caucasian population
S.J. Frost, K. Creed, T. Wheatley, G.B. Firth, UK
|
|
D19 |
The Role of Glycotoxins in Diabetic Thrombosis
T. Gawlowski, B. Stratmann, A. Stirban, M. Negrean, D. Tschoepe, Germany
|
|
|
D20 |
Metformin gum: an alternative method for delivery of biguanides
J. Guevara-Aguirre, D. Saldarreaga, M. Guevara-Aguirre, Saavedra, Ecuador
|
|
|
D21 |
Comparative evaluation of oral antidiabetic agents’ action in hematological and biochemical parameters of patients suffering from Diabetes Mellitus Type 2
F. Iliadis, M. Baltatzi,C. Savopoulos,Hatzitolios,M. Alevizos, D. Karamitsos, Greece
|
|
|
D22 |
Reversal of streptozotocin-induced diabetes following treatment with FGF 2
M.P. Inchovska, V.K. Ogneva,Y.S. Martinova, Bulgaria
|
|
|
D23 |
Chromium-nicotinete (NBC) supplementation (suppl) lowers vascular inflammation levels both in cultured human monocytes exposed to high glucose (HG) and in streptozotocin (STZ)-treated diabetic rats
S.K. Jain, J. Rains, J. Croad, USA
|
|
|
D24 |
CAUSES OF SEVERE VISUAL IMPAIRMENT IN DIABETIC POPULATION
S. Karadeniz, M.T. Yilmaz, Turkey
|
|
|
D25 |
Schisandra chinensis extract prevents the elevation of plasminogen activator inhibitor-1(PAI-1) in KKAy diabetic mice
S.H. Ko, H.S. KiM, M.H. Chung, Korea
|
|
|
D26 |
Hyperglycemic excursions in Type 2 diabetes despite HbA1c levels below 7% detected by continuous glucose monitoring and meal test
K.D. Kohnert, P. Augstein,P. Heinke, E. Zander, K. Peterson, E.J. Freyse, E. Salzsieder, Germany
|
|
|
D27 |
The Effects of Expressions of PKCmRNA and PI-3KmRNA Treated with Aminoguanidine and Tetramethylpyrazine on Type 2 Diabetic Rats
R. Li, S. Wei, X. Zhang, China
|
|
|
D28 |
Carnitine in the treatment of muscle cramps in diabetic patients with renal nephropathy
A. Loli, S. Giannakaki, A. Kokkalis,K. Sonidou,A. Maurommati, M. Tsilivigou, G. Papadakis, Greece
|
|
|
D29 |
THE MAGNESIUM CHANGES AT DIABETIC PATIENTS CORRELATED TO THE NUMBER OF COMPLICATIONS
M. Onaca, I. Szabo, A. Onaca, N. Havasi, Romania
|
|
|
D30 |
Long-term survival of patients with diabetes mellitus and acute stroke
T. Pappa, S. Skalidi,K. Xynos,M. Saliaris, J. Zafeiriou, M. J. Theodorakis, K. Vemmos, Greece
|
|
|
D31 |
OXIDIZED LOW DENSITY LIPOPROTEIN AND TYPE 2 DIABETES MELLITUS
S. Paximadas, S. Pagoni, K. Lempesopoulos, K. Kyriakoulea, Z. Zachariadou, I. Mavrodimitrakis, G. Parvulescou, N.Sakarelou, Greece
|
|
|
D32 |
Increased mortality and morbidity by cardiovascular disease in subjects with type 2 diabetes mellitus associated with non-alcoholic fatty liver disease and left ventricular hypertrophy
L. Pop, C. Pop, R. Hojda,D. Dicu, Romania
|
|
|
D33 |
Significance of Early Diagnosis of Cardiovascular Autonomous Neuropathy in Diabetics
S. M. Popovic-Pejicic, L. Todorovic-Djilas, D. Rodic, Bosnia and Herzegovina
|
|
|
D34 |
The healthy diabetes plate: An effective diabetes self-management nutrition tool
M. Raidl, R. Lanting, M. Spencer, L. Sant, A. Liddil, S. Johnson, J. Welch, M.Lockard, K. Spain, M. Hartman, USA
|
|
|
D35 |
Renal impairment evaluation of type 2 Diabetes mellitus patients: serum cystatin C quantification and qualitative proteinuria evaluated by SDS-agarose gel electrophoresis
R.C. G. Ramalho, C. S. Guimaraes, D. Carvalho, L. D. Delgado, Portugal
|
|
|
D36 |
Is Fibroblast Growth Factor a Marker of Microvascular Disease in Diabetes Mellitus type 1?
G.M. Rocha, A. Carvalho, J. LaFuente,J. Angulo,I. Palma, Portugal
|
|
|
D37 |
The Assessment of Pulmonary Diffusing Capacity in Diabetes Mellitus with Regard to Type and Complications
Z.A. Saglam, G. Cakmak, T. Saler, E. H. Ataoglu, M. Yenigun, O. Arýyurek, Turkey
|
|
| D38 |
The actual conditions of and countermeasures against diabetes mellitus in Japan
A. Sakuta, Japan
|
|
|
D39 |
Prevalence of diabetes mellitus in adults in southeast of Iran 2002
Z. Salem, M.A. Sajjadi, Iran
|
|
|
D40 |
The effect of antioxidant therapy on thyroid autoantibody levels and metabolic parameters in type 1 diabetic patients
T. Saler, Z.A. Saglam, O. Ozmen, E.H. Ataoglu, M. Yenigun, B. Oguzhan, Turkey
|
|
|
D41 |
The impact of demographic features in the development of chronic complications in diabetic patients
T. Saler, Z. A. Saglam, E. H. Ataoglu, Yenigun, Turkey
|
|
|
D42 |
PROCOAGULANT FACTORS IN PATIENTS WITH DIABETES MELLITUS TYPE 2
A.S. Severina, L.D. Chirkova, M.V. Shestakova, Russia
|
|
|
D43 |
Patient and graft survival of type 1 diabetic patients after kidney transplantation comparing with non-diabetics
M.V. Shestakova, E.N. Shamaeva,I.G. Kim,E.S. Stolarevich, N.A. Tomilina, Russia
|
|
|
D44 |
IS ANTI-HYPERGLYCEMIC CONTROL SUFFICIENT FOR PREVENTION OF CARDIOVASCULAR MORBIDITY IN TYPE-2 DIABETIC PATIENTS
R. Shurtz-Swirski, R. Farah,B. Kristal, G. Shapiro, N. Binyaminov, S. Sela, Israel
|
|
|
D45 |
EVALUATION OF PATIENTS WITH DIABETIC FOOT FOR PROGNOSTIC FACTORS
M. Suher, N. Kucuk, E. Koc, Turkey
|
|
|
D46 |
THE ASSOCIATION BETWEEN PERCENTAGE OF BODY FAT WITH CRP AND INSULIN RESISTANCE IN NONDIABETICS
M. Suher, E. Koc, N. Kucuk, Turkey
|
|
|
D47 |
PATIENT APPROVAL OF INSULIN THERAPY IN TYPE 2 DIABETIC PATIENTS
M. Suher, E. Koc, O. B. Serkant, Turkey
|
|
|
D48 |
The correlation between type 2 diabetes and osteoporosis
M. Suher, N. Kucuk, R. Gulsoy,E. Koc,Turkey
|
|
|
D49 |
The role of genetic polymorphisms of ganglioside metabolism on the pathogenesis of type 2 diabetes mellitus in Japanese
S. Suzuki, Y. Hinokio,H. Hirai, T. Miyagi,Y. Oka, Japan
|
|
|
D50 |
Impaired fasting blood glucose levels predict the risk of coronary artery disease in patients referred to coronary angiography
G. Tacoy, G. Erdem, A. S. Balcioglu,K. Okyay,T. Timurkaynak, A. Cengel, Ankara, Turkey
|
|
|
D51 |
Depression rate in diabetics and education status
M.G. Taskale, H. Ergin, A. Ergin, A. B. Kumbasar, Turkey
|
|
|
D52 |
Pathophysiological effects of antioxidants and immunosuppressive agent on oxidative stress and antioxidant systems in experimental diabetes mellitus
N.S. Tawfek, K.G. Taha, Egypt
|
|
|
D53 |
The effect of pre-pregnancy body mass index on delivery outcomes in potential diabetic patients with normal screening for gestational diabetes mellitus
V. Titapant, N. Phithakwatchara, Thailand
|
|
|
D54 |
Safety and tolerability of prolonged-release nicotinic acid (Niaspan®) in patients with diabetes: a subgroup analysis from the NAUTILUS study
A. Vogt, U. Kassner, U. Hostalek, E. Steinhagen-Thiessen, Germany
|
|
|
D55 |
Interrelationships of cardiac autonomic neuropathy (CAN), 24h blood pressure (24h BP) and urinary albumin excetion (UAE) in type 2 diabetics (DM)
M. Weck, Germany
|
|
|
D56 |
Antioxidant modulation of leukocyte toll-like receptor 4 (TLR4) response in type 2 diabetic patients
K.D. Yang, H. Chuang, S. Yeh, Z. Liu, J. Cheng, R.F. Chen, Taiwan
|
|
| D57 |
Does Tai Chi Chan Exercise Improve HbA1c Level and Immune Regulation in Type 2 Diabetic Patients
S.H. Yeh, H. Chuang,L.W. Lin, Hsaio,P.W. Wang, K.D. Yang, Taiwan
|
|
|
D58 |
THE PREVALENCE OF MICROALBUMINURIA IN TYPE 2 DIABETES: DEMAND TURKEY RESULTS I
M.T. Yilmaz, M. Sargin,S. Karadeniz, A. Sengul, B. Oguzhan, Turkey
|
|
|
D59 |
Chronic Complications in Longterm Type 1 and Type 2 Diabetic Patients with Comparable Duration of Diabetes and Poor Glycemic Control: Turkish Diabetes Chronic Complications Trial – TUDIC Results 1
M.T. Yilmaz, S. Karadeniz, M. Sargin, A. Buyukbese, A. Sengul, Turkey
|
|
|
D60 |
Low dose long acting insulin as a therapeutic agent for anorexia nervosa
Y. Avraham,O. Zolotarev, Y. Dagon, I. Magen, L. Vorobiav, B. Van Heukelom, E.M. Berry, Israel
|
|
|
D61 |
RELATIONSHIP OF SERUM ADIPPONECTIN WITH BLOOD LIPIDS, HbA1c and hs-CRP IN TYPE II DIABETIC WOMEN
H. Babaahmadi-Rezaei, M. T. Goodarzi, M. Kadkhodaei-Eliadrani, S. Hadadian Nezhad, Iran
|
|
| D62 |
Celiac disease in diabetic type1 patients
H. Bashiri, A. Hooshmandi, M. Rahimi, A. Keshavarz, H. Madani, H. pashmizadeh, K. shahebrahimi, Iran
|
|
|
D63 |
Primary prevention of type II diabetes mellitus
M. Robatjazi, Iran
|
|
|
D64 |
Comparison of maternal hemoglobin and mean corpuscular volume in gestational diabetes mallitus(GDM) mothers and non-GDM mothers
S.F. Vasegh Rahimparvar, S. Nazary, A. Rezaeepoor, A. Kazemnegad, Iran
|
|
|
D65 |
Epidemiology, risk factors and clinical characteristics of type 1 diabetes among hospitalized children in Urmia, Iran
Z. Yekta, A. Makoie,A. Abbaszadeh, M. Yaghobi, Iran
|
|
|
D66 |
Behavioral, demographic and clinical factors associated with depression among diabetic patients in Urmia, Iran
Z. Yekta, F. Ghavam,F. Jalilvand, R. Latifi, M. Kafili, Iran
|
|
|
D67 |
Demographic and clinical characteristics of ischemic stroke in diabetic and non-diabetic patients in Urmia, Iran
Z. Yekta, F. Sarsarshahi, M. Minaii,M. Kafili, Iran
|
|
|
D68 |
A comparative study of health related quality of life and clinical characteristics in diabetic and non-diabetic hemodilysis patients
Z. Yekta, P. Ahmadpoor,R. Pourali, M. Kafily, Iran |
|
|
|
Hypertension |
|
Board #
|
Poster Title & Author(s) |
|
H69 |
PREVALENCE OF OBESITY AMONG HYPERTENSIVE PATIENTS, ANTIHYPERTENSIVE TREATMENT (AHT) AND SUCCESS RATES
A.I. Hatzitolios, M. Kosmidou, M. Baltazi, P.N. Panagopoulou, C. Dimitroula, C. Savvopoulos, D. Karamitsos, Greece
|
|
H70 |
WHITE COAT HYPERTENSION AND MPV
D.I. Agapakis, E.B. Massa, E. Keramari, Greece
|
|
H71 |
GENDER – BASED OUTCOME MEASURES IN DIABETIC HYPERTENSION: AN ANALYSIS OF DRUG PRESCRIBING PATTERN IN PRIMARY CARE
K.A. J. Al Khaja, R.P. Sequeira, H.H. Damanhori, Bahrain
|
|
H72 |
METABOLIC DISTURBANCES IN TURKISH WOMEN WITH NORMAL FASTING GLUCOSE AND NORMAL BODY WEIGHT
T. Bayraktaroglu, A.S. Cikim, F. Kutluturk, A.D. Azezli , Y. Orhan, Turkey
|
|
H73 |
EFFECTIVENESS AND TOLERABILITY OF EZETIMBLE PLUS ATORVASTATIN CO-ADMINISTATION IN PATIENTS WITH METABOLIC SYNDROME
T. Bayraktaroglu, A.D. Azezli, F. Kutluturk, Y. Orhan, Turkey
|
|
H74 |
FOLIC ACID AND ARGININE, ALONE OR COMBINED, DO NOT REDUCE HIGH NORMAL BLOOD PLESURES IN MIDDLE-AGED PERSONS WITH HYPERHOMOCYSTEINEMIA. A RANDOMIZES, DOUBLE - BLIND, PROSPECTIVE ABDM STUDY
U. Dietz, Germany
|
|
H75 |
THE EFFECT OF OBESITY ON THE BLOOD PRESSURE CHANGES WITH EXERCISE
G. Erdem Yazici, G. Aydogdu Tacoy, B. Alibazoglu, Turkey
|
|
H76 |
OLBEMEST-STUDY: REDUCTION OF BLOOD PRESSURE IN THE TREATMENT OF PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION – CURRENT ANALYSIS OF THE POOLED DATA
S. Ewald, M. Bohm, Germany
|
|
H77 |
AGE: SEEMS TO BE AN IMPORTANT DETERMINANT OF METABOLIC SYNDROME PREVALENCE
P. Freitas, D. Carvalho,C. Sobral, J.A. Prazeres-Silva, J.L. Medina, Portugal
|
|
H78 |
ROLE OF PARATHYROID HORMONE (PTH) IN BLOOD PRESSURE REGULATION IN HYPERTENSIVE DIABETIC (TYPE II) PATIENTS
S. Giannakaki, A. Loli, Nikolaidis, V. Hliopoulos, F. Stasini, G. Papadakis, Greece
|
|
H79 |
THE SPECIFICS OS STRUCTULAR-FUNCTIONAL PARAMETERS OF MYOCARDIUMIN IN THE PATIENTS WITH DIFFERENT DEGREES OF OBESITY, ARTERIAL HYPERTENSION AND CARBOHYDRATE METABOLISM DISTURBANCES
E.R. Giorgadze, T.T. Doliashvili, K.G. Bochorishvili, Gruzia
|
|
H80 |
INCIDENCE OF HYPERTENSION AND PREDICTORS FACTORS OF BLOOD PRESSURE LEVELS IN A COHORT OF PATIENTS WITH TYPE 1 DIABETES
M.B. Gomes, R.A. Cobas, E.F. Cunha, B. Santos, L. Braga, Brazil
|
|
H81 |
THE EFFECT OF ATORVASTATIN ON NA/LI COUNTERTRANSPORT OF RED BLOOD CELLS IN HYPERTENSIVE DYSLIPIDAEMIC PATIENTS (PRELIMINARY RESULTS)
A. Hatzitolios, M. Kosmidou, A. Adamidou, N. Raikos, C. Savopoulos, A. Karagiannis, V.G. Athyros, G.Parharidis, Greece
|
|
H82 |
DOES OBESITY INFLUENCE THE NEPHROPATHY PROGRESSION IN HYPERTENSIVE TYPE 2 DIABETIC PATIENTS?
S.D. Jelic, T. Eror, A. Stanojevic, V.M. Ilic,, Serbia
|
|
H83 |
THE ABNORMALITEIS OF INFLAMMATION MARKERS IN KOREAN OBESE MEN
N.S. Joo, K.M. Kim, B.T. Kim, S.B. Park, M.H. Kong, T.Y. Lee, Korea
|
|
H84 |
THE ANTIHYPERTENSIVE EFFECT OF LIFESTYLE MODIFICATION AND FERMENTED MILK ENRICHED WITH BIOACTIVE PEPTIDES IN SUBJECTS WITH ESSENTIAL HYPERTENSION.
J.H. Kim, H.E. Kim, G.R. Kang, J.Y. Kim, J.H. Choue, R.W. Choue, Korea
|
|
H85 |
SIMILARITIES AND DIFFERENCES AMONG PATIENTS WITH MASKED, WHITE COAT AND SUSTAINED HYPERTENSION
A. Konstantopoulou, I. Papargyriou, S. Liatis, P. Konstantopoulou, D. Papadogiannia, Greece
|
|
H86 |
AUDIT OF THE MANAGEMENT OF HYPERTENSION IN DIABETES PATIENTS
R.N. Kulambil Padinjakara, S. Ghosh, P. Narendran, UK
|
|
H87 |
AGING WORKFORCE AND HEALTH IN A LARGE CHEMICAL COMPANY
C. Oberlinner, S. Lang, G. Ott, A. Zober, Germany
|
|
H88 |
ACUTE INFLAMMATION AND NUTRITION DISORDER BRING INTENSIVE DECREASE OF HIGH DENSITY LIPOPROTEIN
N. Otsu, T. Shirata,M. Yamada,M. Sato, M. Tominaga, M. Mizutani, W. Kimura, Japan
|
|
H89 |
ASSOCIATION BETWEEN THE PURINERGIC RECEPTOR P2 X 6 POLYMORPHISMS AND BLOOD PRESSURE IN AN ENGLISH POPULATION
A. J. Palomino Doza, B. Keavney, D. Hall, J. Eden, T. Rahman, R. Hussain, United Kingdom
|
|
H90 |
HIGH PROTEIN DIET EFFECT ON ARTERIAL BLOOD PRESSURE
E. Papakonstantinou, D. Triantafillidou, D. Panagiotakos, A. Koutsovasilis, M. Saliaris, A. Manolis, A. Melidonis, A. Zampela, Greece
|
|
H91 |
OXIDIZED LOW DENSITY LIPOPROTEIN AND HYPERTENSION
S. Paximadas, S. Pagoni, V. Papalimneou, K. Rousodimos, D. Syrigos, A. Tzovaras, K. Kyriakoulea, N.Sakarelou, Greece
|
|
H92 |
BODY MASS, FAT DISTIBUTION AND BLOOD PRESSURE IN AN ITALIAN PAEDIATRIC POPULATION
F. Pieruzzi, L. Antolini, M. Giussani, S. Galbiati,P. Brambilla, M.G. Valsecchi, A. Stella, Italy
|
|
H93 |
LEVELS OF SYSTOLIC BLOOD PRESSURE (BUT NOT LEVELS OF DIASTOLIC BLOOD PRESSURE) ARE HIGHER IN DIABETIC PATIENTS WITH DIABETIC RETINOPATHY
S.P. Radenkovic, M.M. Pesic,R.D. Kocic,D.N. Dimic,D. Mikic, M. Velojic Golubovic, S. Antic, Serbia
|
|
H94 |
Is stress test useful to planning physical activity in metabolic syndrome?
P. Ripari, M. Soccio,S. Gallina, A. Di Blasio, Italy
|
|
H95 |
METABOLIC SYNDROME: CARDIOVASCULAR RISK PROFILE AND DISTRIBUTION IN A SPANISH WORKING POPULATION REGARDING CARDIOVASCULAR MORTALITY AREAS. THE IBERMUTUAMUR CARDIOVASCULAR RISK PREVENTION STUDY
M.A. Sanchez Chaparro, J. Roman Garcia, E. Calvo-Bonacho, M. Cabrera-Sierra, J.C. Sainz Gutierrez, C. Fernandez-Lavadera, A. Fernandez Meseguer, A.Garcia Garcia, J. Rueda-Vicente, P. Gomez Martinez, A. Galvez Moraleda, A.Gonzalez Quintela, Spain
|
|
H96 |
Evaluation of the validity of McAuley’s index as a measure of insulin sensitivity in hypertensive type 2 diabetic patients
P.A. Sarafidis, A.N. Lasaridis, J.G. Yovos, K. Kazakos, T. Mousleh, M. Pikilidou, A. Kanaki, USA
|
|
H97 |
ISHEMIC NEPHROPATY AND ITS PREVALENCE IN TYPE 2 DIABETES
M.V. Shestakova, M. Shamkhalova, N. B. Smirnova, I. Klefortova, U. I. Buziashvili, V. A. Alpenidze,
E. Tugeeva, Russia
|
|
H98 |
Insulin resistance indexes and metabolic syndrome in overweight/obese patients
J. Silva-Nunes, L. Gardete-Correia, Portugal
|
|
H99 |
The impact of the Pro12Ala PPAR-g gene polymorphism on anthropometric and biochemical parameters describing metabolic syndrome in generally healthy male Polish population
A. Trzmiel, J. Kuliczkowska-Paksej, A. Filus, A. Milewicz, M. Medraoe, Poland
|
|
H100 |
A STUDY OF PROFESSIONAL NURSES’ PERCEPTIONS OF FACTORS AFFECTING THE PROCESS OF CLIENT EDUCTAION
Z. Godarzi, K. Khosravi, K. Vaskooii, F. Youssefi, A. Tole, Iran
|
|
H101 |
EFFECT OF BLOOD PRESSURE CHANGES AND BODY TEMPERATURE DUE TO MORPHINE INJECTION ON SKIN BLOOD FLOW
S. Hajizadeh, Iran
|
|
H102 |
EFFECTS OF BLOOD PRESSURE CHANGES DUE TO MORPHINE INJECTION ON SKIN BLOOD FLOW OF RAT
S. Hajizadeh, F. Safari, Iran
|
|
H103 |
Some laboratory parameters depending on total plasma cholesterol levels in patients with the metabolic syndrome
O.Y. Tomashevska, Ukraine
|
|
|
|
|
Obesity
|
| Board # |
Poster Title & Author(s) |
|
O104
|
EFFECT OF SIBUTRAMINE ON METABOLIC PARAMETERS AND WEIGHT LOSS IN COMBINATION TO A SPECIFIC DIET IN PATIENTS SUFFERING FROM METABOLIC SYNDROME
S.C. Adamidis, G.Z. Panos, S.S. Adamidis, Greece
|
|
O105
|
GHRELIN VARIANTS AND BIOCHEMICAL AND ANTHROPOMETRICAL PARAMETERS IN CZECH POPULATION AND WEIGHT LOSS IN INTERVENTION STUDY
V. Adamkova, J.A. Hubacek, R. Bohuslavova, P. Suchanek, Czech Republic
|
|
0106
|
MODIFICATION OF BODY WEIGHT (BW), WAIST CIRCUMFERENCE (WC) AND BODY COMPOSITION AFTER LAPAROSCOPIC ADJUSTABLE GASTRIC BANDING (LAGB) AND HYPOCALORIC BALANCED DIET
E.B. Adamo, H. Marini, C. Musolino, R. Marini, C. Milici, M.T. Vigo, S. Benvenga, G.Navarra, Italy
|
|
O107
|
EFFICACY AND SAFETY OF USED SIBUTRAMINE FOR TREATMENT OF OBESITY
D.I. Agapakis, E.B. Massa, T.K. Kechidou, Greece
|
|
O108
|
ADIPOSITY AND VASCULAR FUNCTION - THEIR RELATIONSHIP IN POSTNATAL WOMEN
M. Banerjee, A. Vyas, R.A. Malik, J.K. Cruickshank, UK
|
|
O109
|
TRIGLYCERIDES LEVELS AND TRIGLYCERIDES / HIGH-DENSITY LIPOPROTEIN CHOLESTEROL RATES WITH INDICES OF INSULIN RESISTANCE IN OBESE AND OVERWEIGHT TURKISH WOMAN
T. Bayraktaroglu, A.S. Cikim, F. Kutluturk, A.D. Azezli, Y. Orhan, Turkey
|
|
O110
|
PHYSICIANS FREQUENTLY OVERESTIMATE THE SEVERITY OF OVERWEIGHT/OBESITY IN THEIR PATIENTS: AN ANALYSIS FROM THE PAN-EUROPEAN SURVEY OF HDL-CHOLESTEROL
E. Bruckert, M. Baccara-Dinet, France
|
|
O111
|
SENSITIVITY OF TWO ANTHROPOMETRIC VARIABLES FOR METABOLIC SYNDROME (METS) DIAGNOSIS, IN OVERWEIGHT ADOLESCENT
R.A. Burrows, B. Diaz, B. Leiva, A.M.B. Tong, J. Aldunate, L. Lera, C. Albala, Chile
|
|
O112
|
POSTPRANDIAL LEVELS OF HORMONES: GHRELIN AND LEPTIN IN OBESE PATIENT AND ITS CORRELATION WITH METABOLIC PARAMETERS
I. Leszczynska-Golabek, A.M. Dembinska-Kiec, M. Malczewska-Malec, Poland
|
|
O113
|
A MURINE MODEL OF INSULIN RESISTANCE WITH MODERATE OR EXTENSIVE HYPERCHOLESTEROLEMIA SUITABLE TO INVESTIGATE CARDIOVASCULAR FETAL PROGRAMMING BY MATERNAL METABOLIC SYNDROME
C. Eberle, W. Palinski, USA
|
|
O114
|
ASSOCIATION BETWEEN TRACKING OF OVERWEIGHT FROM CHILDHOOD TO ADOLESCENCE AND RISK FACTORS OF METABOLIC SYNDROME IN ADOLESCENTS: A TEN-YEAR RETROSPECTIVE STUDY
K.R. Kim, Y.J. Shin, B.Y. Choi, M.K. Kim, Korea
|
|
O115
|
RELATIONSHIP BETWEEN SERUM MAGNESIUM LEVELS AND METABOLIC RISK FACTORS IN OVER WEIGHT AND OBESE TURKISH WOMEN
F. Kutluturk, T. Bayraktaroglu, A. Sertkaya Cikim, A. Azezly, Y. Orhan, Turkey
|
|
O116
|
EVALUATION OF INSULIN RESISTANCE AND ADPONECTIN LEVEL IN RESPONSE TO STANDARDIZED PHYSICAL EFFORT IN OBESE POSTMENOPAUSAL WOMEN
F. Lwow, A. Milewicz, K. Dunajska, D. Jedrzejuk, A. Szuba, Poland
|
|
O117
|
EFFECT OF ORLISTAT ON WOMEN WITH EXCESS OF WEIGHT AFTER BEING SURGICALLY TREATED WITH LIPOSUCTION
I.M. Marti, J. S. Sanchez, N. S. Sarobe, J. B. Ballesta, J. Y. Ybarra, Spain
|
|
O118
|
IMPACT OF OBESITY ON ATRIAL SIZE OF WOMEN WITH NEW ONSET ATRIAL FIBRILLATION
V.N. Nicolaou, I.E. Papadakis, A.V. Karazahos, D.T. Bogiatzis, P.G. Marnelos,
S.I. Dermitzaki,V.T. Pastromas, I. Liossis, A.K. Tsakiris, P.D. Skoufas, Greece
|
|
O119
|
OBESITY IS AN INDEPENDENT RISK FACTOR FOR PLASMA LIPID PEROXIDATION AND DEPLETION OF ERYTHROCYTE CYTOPROTECTIC ENZYMES IN HUMANS
S.O. Olusi, Kuwait
|
|
O120
|
EFFECTS OF HIGH PROTEIN DIET ON BODY COMPOSITION
E. Papakonstantinou, D. Triantafillidou, D. Panagiotakos, A. Koutsovasilis, M. Saliaris, A. Manolis, A. Melidonis, A.Zampelas, Greece
|
|
O121
|
EFFECTS OF HIGH PROTEIN ON GLYCEMIC CONTROL OF OBESE INDIVIDUALS WITH TYPE 2 DIABETES
E. Papakonstantinou, D. Triantafillidou, D. Panagiotakos, A. Koutsovasilis, M. Saliaris, A. Manolis, A. Melidonis, A.Zampelas, Athens, Greece
|
|
O122
|
ACE I/D POLYMORPHISM AND METABOLIC PARAMETERS IN OBESE BUT METABOLICALLY HEALTHY INDIVIDUALS
D. Papazoglou, T. Papadopoulos, P. Papathanasiou, K. Papatheodorou, N. Papanas, G. Goutis, T. Gioka, E.Maltezos, Greece
|
|
O123
|
EFFECT OF WEIGHT-REDUCING DIET ON TOTAL PLASMA ADIPONECTIN CONCENTRATION AND QUANTITY OF ADIPONECTIN POLYMERIC ISOFORMS IN OBESE WOMEN
J. Polak, Z. Kovacova, M. Jacek, E. Klimcakova, M. Bajzova, M. Kovacikova, M. Vitkova, V.Stich, Czech Republic
|
|
O124
|
THE ECONOMICS OF OBESITY OR WHY OBESE CHILDREN ARE TALLER? AND ON LOW MUSCLE MASS - A SPECIAL GENRE OF OBESITY
D. Ralt, Israel
|
|
O125
|
6TH MONTH FOLLOW-UP OF A MORBID OBESE PATIENT BEFORE AND AFTER GASTRIC BAND SUGERY: EVALUATION OF NUTRITIONAL AND IMMUNE PROTEIN PROFILES
R.C. G. Ramalho, C.S. Guimarães, C. Gil, C. de Oliveira, L. Delgado, Portugal
|
|
O126
|
OBESITY DAY AND ADI- AN ITALIANA EXPERIENCE
G.M. Rovera, M.A. Fusco, C. Lesi, E. Mirri, M. Palazzi, M.L. Amerio, F. Leonardi, P. Pallini, P. Nanni, N. Facchin, A.R. Sabbatini, G. Fatati, Italy
|
|
O127 |
OBESITY, HYPERTENSION AND DIABETES: ITS INFLUENCE ON THE SPANISH WORKING POPULATION´S METABOLIC SYNDROME PREVALENCE. IBERMUTUAMUR CARDIOVASCULAR RISK PREVENTION STUDY
M.A. Sanchez-Chaparro, J. Roman-Garcia, E. Calvo-Bonacho, C. Fernandez-Lavandera, M. Cabrera-Sierra. J.C. Gutierrez-Sainz, A. Fernandez-Meseguer, A.Garcia-Garcia, P. Gomez-Martinez, J. Rueda-Vicente, A. Galvez-Moraleda, A. Gonzalez-Quintela, Spain
|
|
O128
|
OBESITY AND MATERNITY STANDARDS
S. Sathiyathasan, K. Sivanesan, UK
|
|
O129
|
DISCOVERY OF A NOVEL CANNABINOID-1 RECEPTOR INVERSE AGONIST
C.P. Shen, L.S. Lin, J. Lao, J.C. Xiao, L. Van der Ploeg, M T. Goulet, W.K. Hagmann, T. J.Lanza, J.P. Jewell, P. Liu, S.S. Shah, H. Qi, USA
|
|
O130
|
INTERLEUKIN-6 LEVELS AND ADRENAL FUNCTION IN OBESE PATIENTS
J. Silva-Nunes, C. Santos, C. Godinho,I. Rodrigues, E. Arranhado, M.F. Vaz, H. Lages, L.Gardete-Correia, Portugal
|
|
O131
|
THE ASSOCIATION BETWEEN BODY MASS INDEX AND SOCIO-DEMOGRAPHIC DETAILS IN TURKISH WOMEN
M. Suher, E. Koc, N. Ata, Turkey
|
|
O132
|
COMPARING THE PREVALANCE OF COMORBID DISEASES and LABOROTARY CHANGES OF MORBIDLY OBESE AND OBESE PATIENTS
M. Suher, I.H. Kalkan, E. Koc, Turkey
|
|
O133
|
DISTURBANCES OF HEMOSTASIS IN THE METABOLIC SYNDROME
O.Y. Tomashevska, Y.I. Dzis, Ukraine
|
|
O134
|
VISFATIN AND RESISTIN MRNA EXPRESSION FROM PERIPHERAL MONONUCLEAR CELLS IS INCREASED IN OVERWEIGHT WOMEN WITH IMPAIRED GLUCOSE TOLERANCE
P.C. Tsiotra, C. Tsigos, A. Koukourava, E.S. Anastasiou, S.A. Raptis, Greece
|
|
O135
|
RELATIONSHIP OF METABOLIC SYNDROME TO DIETARY CARBOHYDRATE, GLYCEMIC INDEX AND GLYCEMIC LOAD AMONG ADULTS IN KOREA
S.H. Yun, K. R. Kim, B.Y. Choi, M.K. Kim, Korea
|
|
O136
|
OBESITY AND RISK OF CESAREAN DELIVERY: A POOLED ANALYSIS
S.Y. Chu, Y. Kim, P. Dietz, J. Lau, C.H. Schmid, K. Curtis, USA
|
|
O137
|
RELATIONSHIP BETWEEN ADOLESCENTS NUTRITIONAL RELATIONSHIP BETWEEN ADOLESCENTS NUTRITIONAL BEHAVIOR AND PHYSICAL ACTIVITY WITH THEIR PERCEPTION FROM PARENTS'LIFESTYLE BEHAVIORS IN THE GIRLS GUIDANCE SCHOOLS
A. Rezaeipour, M. Shakeri, F. Yousefi, M. Mahmoodi, Iran
|
|
O138
|
ASSOCIATION BETWEEN ABDOMINAL FAT AND DEPRESAMONG PREMENOPAUSAL WOMEN THOSE SION REFERS TO THE MEDICAL CENTERS OF POST COMPANY
M. Ghavamsadri, N. Tehrani, Iran
|
| O139 |
Postprandial lipaemia/glycaemia in patients with familial obesity and pro12Ala polymorphism in PPAR-gamma2
M. Malczewska-Malec, A.M. Dembinska-Kiec, L. Partyka, I. Leszczynska-Golabek, B. Kiec-Wilk, Poland
|
| O140 |
What should be the ideal body mass index?
A. Al-Awadhi, O. Olusi, Kuwait
|
| O141 |
A COMPARISON OF THE PREVALENCE OF THE METABOLIC SYNDROME IN THE ADULT POPULATION OF CENTRAL GREECE USING THREE PROPOSED DEFINITIONS
G.N. Koukoulis, F.T. Katsaros , S.I. Tsirona, S. Mountantonakis, M. Goutou, C. Sakka, Greece
|
| O142 |
Comparison of serum leptin in Tehranian pre and postmenopausal women
M. Shaikoleslami, H. Hamayeli Mehrabani, P. Mirmiran, F. Azizi, I. Elmadfa, Iran
|
| O143 |
Comparison of the effects of gliclazide and glibenclamide on insulin resistance and metabolic parameters
Z. A. Saglam, E. H. Ataoglu, M. Yenigun, R. D. Gokturk, L. U. Temiz, Turkey
|
| O144 |
A COMPARISON OF THE PREVALENCE OF THE METABOLIC SYNDROME IN THE ADULT POPULATION OF CENTRAL GREECE USING THREE PROPOSED DEFINITIONS
G. N. Koukoulis, F. T. Katsaros, S. I. Tsirona, S. Mountantonakis, Greece
|
| 145 |
The association between carotid artery intima-media thickness and cardiovascular mortality and morbidity in type 2 diabetes: a retrospective study
Z. A. Saglam, M. Yenigun, T. Saler, E. H. Ataoglu, L. U. Temiz, F. Cetin, Z. Yigit, F.Sar. B. Kumbasar, Turkey
|
| 146 |
The Use of Doppler Echocardiograph with Ankle-Brachial Index for Determining the Vascular Problems in the Diabetic Foot
F. Gokdogan, M. N. Catakoglu, Y. Gunduz, M. K. Kayabas, H. Koca, S. Kazak, S. Yorgun, H.Alpteker, Turkey
|
|
147 |
The Prevalence of Diabetic Retinopathy in Diabetic Patients with History of Diabetic Foot Ulcer
M. N. atakoglu, F. Gokdogan, F. Yýlmaz, N. Xafak Yis, H. Koca, S. Yorgun, S. Can, H.Alpteker, Turkey
|
| 148 |
The influence of the mediterranean diet on the development of the metabolic syndrome in a sample of young greek navy recruits
K. Makrilakis, J. Doupis, C. Dimosthenopoulos, D. Perrea, K. Diamanti, S. A. Raptis, N. L. Katsilambros, Greece
|
| 149 |
The effect of the quality of carbohydrate on glucose response and endurance capacity
N. Salarkia, F. A. Taleban, K. Sharifiazar, Iran
|
| 150 |
PERIPHERAL NEUROPATHY IN TYPE 2 DIABETES MELLITUS IN ISFAHAN, IRAN: PREVALENCE AND RISK FACTORS
M. J. Janghorbani, H. R. Rezvanian, A. K. Kachooei, Ghorbani, A. Chitsaz, F. Izadi, M. Amini, Iran
|
| 151 |
Study of urinary crystals for the diabetics subjects (Type I)
B. Kacem, A. Belouatek, A. A. Benahmed, A. Semmoud, A. Addou, Morocco
|
| 152 |
|
The effect of red seed grape on lipid serum levels of hypercholestrolemia subjects
S. Fattahi, M. M. Shakoori, A. Aminpoor, B. Golestan, Iran | |
| 153 |
Hypertention and obesity in diabetes
F. Youssefi, Z. Goudarzi, A. Youssefi, Iran
|
| 154 |
ACE inhibition escape phenomenon in patients with type 2 diabetes and diabetic nephropathy
N. Trubitcyna, M. Shamkalova, M. Shestakova, A. Ilin, Gulnara Katsya, N. Goncharov, A. Deev, Russia
|
| 155 |
GPs’ motivations when starting a new oral bitherapy in adult patients With Type 2 Diabetes Mellitus and the reactions of these patients
F. Allaert, D. Pouchain, B. Valtier, D. Gerard, C. Charpentier, France
|
| 156 |
Persistent obesity - can it be managed effectively by a general practitioner?
P. Hatzialexiadi, P. Vassiliu, R. P. Rotas, O. Liouliou, Greece
|
| 157 |
The effect of surgical cure of acromegaly on glycaemic control in an elderly female patient suffering from type 2 diabetes - the case report K. Milenkovic Vulovic, Serbia |
|
|
|
| |
|
|
